Episode Summary
In this Podcast, we discuss early NSCLC management and treatment, particularly in light of how immunotherapy will impact surgical and respiratory medicine as the landscape evolves with new data. A/Prof Melissa Moore is joined by Dr Katharine See and Dr Naveed Alam to discuss and review the findings and implications for NSCLC patients.
Thank you to Roche for collaborating on this podcast.
Show Hosts
This episode’s host are:
- A/Prof Melissa Moore, Educational Chair, TOGA; Medical Oncologist
- Dr Katharine See, Director and Head of Respiratory Medicine, Northern Hospital, Melbourne
- Dr Naveed Alam, Thoracic Surgeon, St Vincent’s Hospital and Epworth